Regulation of the Immune Cell Repertoire in Psoriasis Patients Upon Blockade of IL-17A or TNFα

• Autori principali: Julia Tittes (Autore), Jennifer Brell (Autore), Pia Fritz (Autore), Constanze Jonak (Autore), Georg Stary (Autore), Julia M. Ressler (Autore), Sarojinidevi Künig (Autore), Wolfgang Weninger (Autore), Johannes Stöckl (Autore)
• Natura: Libro
• Pubblicazione: Adis, Springer Healthcare, 2024-03-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Abstract Introduction Targeting of the proinflammatory cytokine interleukin 17A (IL-17A) or tumor necrosis factor alpha (TNFα) with the monoclonal antibodies (mAbs) ixekizumab or adalimumab, respectively, is a successful therapy for chronic plaque psoriasis. The effects of these treatments on immune...